retatrutide phase 2 trial results Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized 2a New Retatrutide Phase 3 Trial

Frequently asked questions Tesamorelin and sermorelin are both growth hormone-releasing hormone (GHRH) analogs, but tesamorelin is more potent and specifically FDA-approved for reducing visceral fat in HIV-associated lipodystrophy, while sermorelin is primarily used for anti-aging, muscle growth, and general GH stimulation

Dynamic imaging is one of ultrasounds key features

Bruning U, Morales-Rodriguez F, Kalucka J, Goveia J, Taverna F, Queiroz KCS, et al

Frequently Asked Questions What is BPC-157 and why is it being studied for GERD

Voltage-dependent Na+ and Ca2+ currents in human pancreatic islet beta-cells: evidence for roles in the generation of action potentials and insulin secretion